Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSN-013 (E4/DRSP) for pelvic pain in Japanese women with endometriosis
jRCT2031250241Recruiting
- Sponsor
- Fuji Pharma Co., Ltd.
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of estetrol in endometriosis (2 arms), sponsored by Fuji Pharma Co., Ltd. Primary endpoint: Change in most severe pelvic pain (lower abdominal pain / back pain). Started Aug 2025; status: recruiting.
02
Drugs
estetrol
03
Conditions
endometriosis
Beyond the preview
Go deeper on jRCT2031250241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250241.